LMOD2 reduces Ang II-induced cardiomyocyte hypertrophy via Nrf2 antioxidant pathway
Audio narration · Coming soon
This study reveals that LMOD2 expression decreases in angiotensin II-induced cardiomyocyte hypertrophy, a key factor in heart failure progression. Overexpression of LMOD2 significantly reduces cardiomyocyte enlargement and hypertrophic markers by activating the Nrf2-mediated antioxidant pathway, suggesting a protective role against pathological cardiac hypertrophy.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews